Top compounds associated with response to C22orf31


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA KIN001-244 GDSC1000 pan-cancer AAC 0.05 0.1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.074 0.1
mRNA MS-275 gCSI pan-cancer AAC -0.083 0.1
mRNA bendamustine CTRPv2 pan-cancer AAC 0.059 0.1
mRNA foretinib CTRPv2 pan-cancer AAC 0.055 0.1
mRNA PHA-665752 CCLE pan-cancer AAC -0.071 0.1
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.059 0.1
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.05 0.1
Download CSV